Sarepta Therapeutics 4.95M share Spot Secondary priced at $25.25 The deal priced at the high end of the $25.00-$25.25 range and was increased to $125M in common stock. Lazard Capital acted as sole book running manager for the offering.
News For SRPT From The Last 14 Days
Check below for free stories on SRPT the last two weeks.
Sarepta said to cancel appearance at Needham conference Sarepta cancelled its appearance at Needham's conference tomorrow due to "other obligations," a re-tweet by The Street's Adam Feuerstein says, citing a confirmation from the company. Shares of Sarepta moved up 23c to $23.37 following circulation of the tweet.